Zions Bancorporation, National Association’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$825K Sell
6,047
-4,753
-44% -$584K 0.05% 177
2026
Q1
$1.27M Sell
10,800
-1,895
-15% -$265K 0.08% 138
2025
Q4
$2.08M Sell
12,695
-880
-6% -$138K 0.1% 143
2025
Q3
$1.81M Sell
13,575
-2,018
-13% -$245K 0.09% 152
2025
Q2
$1.94M Buy
15,593
+672
+5% +$85.5K 0.1% 167
2025
Q1
$1.9M Buy
+14,921
New +$2.3M 0.12% 159

Other funds holding RGEN

Zions Bancorporation, National Association's RGEN Position: Q2 2026 in Review

Zions Bancorporation, National Association reduced its Repligen (RGEN) stake by 44% in Q2 2026, selling an estimated $584K and leaving 6,047 shares worth $825K. The position accounts for 0.05% of the portfolio, ranked #177.

Zions Bancorporation, National Association first reported a position in RGEN in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.08M in Q4 2025. 152 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Zions Bancorporation, National Association held 6,047 shares of Repligen worth $825K as of Q2 2026.
  • Zions Bancorporation, National Association sold 4,753 Repligen shares in Q2 2026, an estimated $584K.
  • Repligen made up 0.05% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #177 holding.
  • Zions Bancorporation, National Association first reported a position in Repligen in Q1 2025 and has held it in 6 quarters since.
  • Zions Bancorporation, National Association's Repligen position peaked at $2.08M in Q4 2025.
  • 152 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.